Hultin L E, Matud J L, Giorgi J V
The Multicenter AIDS Cohort Study and UCLA School of Medicine, Los Angeles, California 90095-1745, USA.
Cytometry. 1998 Oct 1;33(2):123-32. doi: 10.1002/(sici)1097-0320(19981001)33:2<123::aid-cyto6>3.0.co;2-k.
For some membrane-associated antigens, the number of molecules expressed per cell carries information about the cell's differentiation and activation state. Quantitating antigen expression by flow cytometry has immediate application in monitoring CD38 expression on CD8+ T cells in human immunodeficiency virus 1-associated disease, where elevated CD38 antigen expression is a marker of CD8+ T-cell activation and a poor prognostic indicator. Reproducible methods are needed in order to quantify such antigens. Here we describe a reproducible method for quantitative fluorescence cytometry (QFCM) that depends on the tightly regulated expression of CD4 antigen on human CD4+ T lymphocytes, which we estimated in a study of 57 normal donors to have an interperson coefficient of variation of 4.9%. Using phycoerythrin (PE)-conjugated CD4 monoclonal antibody (mAb) with a nominal fluorochrome to protein ratio of 1:1 and a nominal published value of approximately 50,000 CD4 antibody molecules bound per CD4+ T lymphocyte, we estimated the number of PE molecules detected per relative fluorescence intensity (RFI) unit on our flow cytometer to be 41 (19, 20). This value is called the "RFI multiplier." To estimate the number of CD38 antibodies bound per CD8+ T cell (CD38-ABC) on patient samples, we multiply the measured CD38 RFI value of CD38 staining using a nominal 1:1 conjugate of CD38-PE by the "RFI multiplier." The measurements for CD4 and CD38 were stable for 2 years despite the use of different mAb lots and the potential for drift in instrumentation. We used this approach in a study of nine flow cytometers in which the interinstrument interlaboratory coefficients of variation for CD3-ABC ranged from 3.3% to 5.8% and those for CD38-ABC ranged from 9.8% to 13.8%. These data indicate that CD4 expression can serve as a biological calibrator to standardize fluorescence intensity measurements in longitudinal and multicenter studies.
对于一些膜相关抗原,每个细胞表达的分子数量携带有关细胞分化和激活状态的信息。通过流式细胞术定量抗原表达在监测人类免疫缺陷病毒1相关疾病中CD8 + T细胞上的CD38表达方面有直接应用,其中CD38抗原表达升高是CD8 + T细胞激活的标志物和不良预后指标。为了定量此类抗原,需要可重复的方法。在这里,我们描述了一种用于定量荧光细胞术(QFCM)的可重复方法,该方法依赖于人类CD4 + T淋巴细胞上CD4抗原的严格调控表达,我们在对57名正常供体的研究中估计其人际变异系数为4.9%。使用藻红蛋白(PE)偶联的CD4单克隆抗体(mAb),其荧光染料与蛋白质的标称比例为1:1,每个CD4 + T淋巴细胞结合的CD4抗体分子标称公布值约为50,000,我们估计在我们的流式细胞仪上每个相对荧光强度(RFI)单位检测到的PE分子数量为41(19,20)。这个值被称为“RFI乘数”。为了估计患者样本中每个CD8 + T细胞结合的CD38抗体数量(CD38 - ABC),我们将使用标称1:1的CD38 - PE偶联物进行CD38染色的测量CD38 RFI值乘以“RFI乘数”。尽管使用了不同批次的mAb以及仪器存在漂移的可能性,但CD4和CD38的测量在2年内保持稳定。我们在一项对九台流式细胞仪的研究中使用了这种方法,其中CD3 - ABC的仪器间实验室变异系数范围为3.3%至5.8%,CD38 - ABC的变异系数范围为9.8%至13.8%。这些数据表明,在纵向和多中心研究中,CD4表达可以作为生物校准物来标准化荧光强度测量。